Clinical Trials
5 trialsNCT07270263 2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA Recruiting
NCT06474182 2025-09-25
ProApix
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Recruiting
NCT02066454 2025-08-13
MYELAXAT
University Hospital, Grenoble
Phase 3 Completed
NCT04106700 2021-02-15
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
Instituto de Investigacion Sanitaria La Fe
Phase 2 Terminated
NCT02958969 2019-12-17
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Dana-Farber Cancer Institute
Phase 4 Completed